Nick Kadysh, CEO of PharmAla discusses the first authorized MDMA treatment of a patient outside of a clinical trial in Canadian history.
Find more of Jon Liedtke’s opinion and commentary on AM800 CKLW HERE
Nick Kadysh, CEO of PharmAla discusses the first authorized MDMA treatment of a patient outside of a clinical trial in Canadian history.
Find more of Jon Liedtke’s opinion and commentary on AM800 CKLW HERE
by
Tags:
Leave a Reply